RecruitingPhase 2NCT06401538
BMB-101 in Absence Epilepsy and DEE
Studying Epilepsy with eyelid myoclonia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bright Minds Biosciences Pty Ltd
- Principal Investigator
- Terence O'Brien, MD, M.DThe Alfred
- Intervention
- BMB-101(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2024 – 2025
Study locations (5)
- The Prince of Wales Hospital, Randwick, New South Wales, Australia
- Royal Brisbane and Womans Hospital, Herston, Queensland, Australia
- St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
- Austin Health, Heidelberg, Victoria, Australia
- Alfred Health, Melbourne, Victoria, Australia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06401538 on ClinicalTrials.govOther trials for Epilepsy with eyelid myoclonia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07535541A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)University of Virginia
- ENROLLING BY INVITATIONNANCT07526428Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary AssessmentSonova AG
- RECRUITINGNANCT07506148Group-Based Acceptance and Commitment Therapy Versus Active Control in University Students With Emotional SymptomsMónica Larrosa Signorelli
- RECRUITINGNANCT06906926Harmony TPV EMEA PMSMedtronic Cardiovascular
- ACTIVE NOT RECRUITINGNCT02337244Zimmer POLAR Persona - TKA (EMEA Study)Zimmer, GmbH